• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image

    Boost Biotherapeutic Quality: Innovative Approaches to Sequence Variant Analysis


    Free Virtual Event & Downloadable Resource

    On-demand

    About the Event & Free Downloadable Resource

    Virtual Event: Boost Biotherapeutic Quality: Innovative Approaches to Sequence Variant Analysis


    Join us for an insightful webinar to explore the critical impact of sequence variants on protein therapeutics and learn advanced methods for their detection and control.


     What You’ll Learn:

    • Impact of Variants: Discover how sequence variants in proteins can alter drug efficacy, stability, and trigger immune responses.
    • Detection Techniques: Learn about icIEF-UV/MS workflows on the Intabio ZT system and EAD-enabled LC/MS methods on the ZenoTOF 7600 system for identifying challenging variants.
    • Real-World Application: Dive into a case study where a cell and developability science team identified a previously uncharacterized sequence variant and developed a mitigation strategy.


    Who Should Attend:

    • Anyone Interested in Protein Therapeutics and Sequence Variants
    • Biopharmaceutical Professionals (Scientists, Engineers, and Project Managers)
    • Quality and Regulatory Specialists
    • Analytical Chemists


    Register now to stay ahead in biotherapeutic development and ensure your drug’s success.

    All attendees will receive an attendance certificate. 


    Free Downloadable Resource: Navigating Stability Challenges in Protein Therapeutics


    This detailed one-pager is a sneak peek of the Infographic available this Autumn. The infographic offers scientists detailed methodologies for addressing stability challenges in protein therapeutics. Learn about advanced analytical techniques and their practical applications in improving drug development.


    What you will learn about:

    • Understanding the impact of charge variant heterogeneity on protein stability
    • Employing icIEF-UV/MS workflows for detailed analysis of molecular structures
    • Identifying chemical modifications such as trisulfide bonds and free thiol groups
    • Strategies for optimizing therapeutic candidate selection and development

    Our Speakers

    image placeholder
    K
    Kristen Nields
    Principal Scientist
    Johnson & Johnson Innovative Medicine
    image placeholder
    RS
    Riley Schaefer
    Co-Op Scientist II
    Johnson & Johnson Innovative Medicine

    Our Sponsor

    Partner logo

    We Are Live In

    0
    DAYS
    0
    HOURS
    0
    MINUTES
    0
    SECONDS
Looking for your ticket? Contact the organizer
Looking for your ticket? Contact the organizer